COESPINE: Comparison Erect Spine in Cardiac Surgery

Sponsor
Instituto do Coracao (Other)
Overall Status
Recruiting
CT.gov ID
NCT04313959
Collaborator
(none)
40
1
2
14.9
2.7

Study Details

Study Description

Brief Summary

Open cardiac surgeries are characterized by the increased use of opioids and longer extubation times, being post-sternotomy pain one of the causes of greater patient discomfort, plexus blockages have been used more frequently given the good results of anatomical studies and case series that are just beginning to be published. however, there is not enough data to convince the scientific community of its advantages, continuing to carry out its performance due to lack of evidence. Dexamethasone also shows an excellent result blocking the inflammatory chain and it was evidenced that it prolongs the time of blockages when used perineurally in the plexus blockages. This study wants to show the improvement of pain in patients who undergo this type of surgery and also show the advantages of a longer blockage, which can reduce use of analgesic and opioids, as well as decrease the time of hospitalization This is a double-blinded, randomized, clinical trial designed to determine the efficacy of spine erector whit dexamethasone gives more duration of the blockage and less pain after cardiac surgery.

Condition or Disease Intervention/Treatment Phase
  • Drug: Ropivacaine 0.2% Injectable Solution
  • Drug: Ropivacaine 0.2% + Dexamethasone
Phase 3

Detailed Description

Evaluation of acute pain pos cardiac surgery in patients that who were subjected at myocardial revascularization. We offer Espine erector block (ESP) with linear array Transducer and needle 100mm bilateral as a technique that offer results more hopeful and less invasive in patients with open cardiac surgery. Favoring the implementation of Fastrack anesthesia techniques in cardiac surgery and minimizing complications in this group of patients

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Comparison of Two Anesthetic Techniques in Blocking the Erector Plane of the Spine Bilateral in Cardiac Surgery: a Prospective Randomized Double-blinded Clinical Trial
Actual Study Start Date :
Jan 20, 2022
Anticipated Primary Completion Date :
Feb 25, 2023
Anticipated Study Completion Date :
Apr 17, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Local anesthetic

Patients assigned for local anesthetic group will receive a single-shot ultrasound-guided erector spine plane block with 25 mL of 0.2% of ropivacaine

Drug: Ropivacaine 0.2% Injectable Solution
Single-shot ultrasound-guided erector spine plane block of 0.2% ropivacaine
Other Names:
  • Do not have
  • Active Comparator: Local anesthetic + steroid

    Patients assigned for local anesthetic + steroid group will receive a single-shot ultrasound-guided erector spine block plane with 25 mL of 0.2% of ropivacaine with 5 mg dexamethasone

    Drug: Ropivacaine 0.2% Injectable Solution
    Single-shot ultrasound-guided erector spine plane block of 0.2% ropivacaine
    Other Names:
  • Do not have
  • Drug: Ropivacaine 0.2% + Dexamethasone
    Addiction of 5 mg/ml dexamethasone in 0.2% ropivacaine solution
    Other Names:
  • Do not have
  • Outcome Measures

    Primary Outcome Measures

    1. Pain intensity score [Within 7 days after cardiac surgery]

      Changes in Numeric Rating Scale (NRS) and visual analogue scale (VAS) will be recorded daily at postoperative 1 to 7 day or until the patient's hospital discharge if this occurs before 7 days. Numerical rating scales A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable VAS have also been utilized in EMA research. VAS are measures of subjective or behavioral experience (e.g., pain, physical exercise). They are typically presented as a 10 cm line with descriptive anchors at each end, such as "completed all prescribed activities today" to "completed none of the prescribed activities today." Respondents place a vertical line through the point on the scale that best fits their experience with that construct at that moment.

    Secondary Outcome Measures

    1. Total opioids consumption [Up to 2 postoperative day]

      The total amount of opioids given by patient

    2. Pain intensity score [Up to 90 days]

      Changes inThe Brief Pain Inventory (BPI).will be recorded after discharge at 30 days, 60 days and 90 days after surgery *The Brief Pain Inventory (BPI) rapidly assesses the severity of pain and its impact on functioning; BPI Pain Items, Least pain in last 24 hours, Pain on average, Pain right now, Worst pain in last 24 hours; BPI Interference Items, Mood, Walking ability, Normal work (including housework), General activity, Relations with other people, Sleep, Enjoyment of life

    3. Duration of mechanical ventilation [Within 7 days after cardiac surgery]

      Duration in hours from the intraoperative intubation up to postoperative extubation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Coronary artery bypass graft with cardiopulmonary bypass

    • Left ventricular ejection fraction ≥ 45%

    Exclusion Criteria:
    • Reoperation

    • Low cardiac output syndrome

    • Preoperative coagulopathy

    • Presence of ventricular assist device other than intraaortic ballon pump

    • Emergency procedures

    • Bacterial or fungal infection in the preceding 30 days

    • Active neoplasia

    • Allergy or intolerance to steroids

    • Allergy to ropivacaine

    • Patient refusal

    • Participation in other study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Incor - Heart Institute - University of Sao Paulo Sao Paulo Brazil 05403000

    Sponsors and Collaborators

    • Instituto do Coracao

    Investigators

    • Principal Investigator: Luis Alberto Rodriguez Linares, MD, INCOR FMUSP

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Filomena R B G Galas, Associate Professor of Anesthesiology at University São Paulo Medical School, Instituto do Coracao
    ClinicalTrials.gov Identifier:
    NCT04313959
    Other Study ID Numbers:
    • 27166919.3.0000.0068
    First Posted:
    Mar 18, 2020
    Last Update Posted:
    Jul 18, 2022
    Last Verified:
    Jul 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Filomena R B G Galas, Associate Professor of Anesthesiology at University São Paulo Medical School, Instituto do Coracao
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 18, 2022